持田製薬(株)の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証PRM | 医薬品 | 4534/E00947 | - |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2014/10/10 | 日証協 | 62,954株 | -10.22% | 8,300株 | -81.96% | 72,249株 | -8.77% | 4,970株 | -59.26% |
| 2014/10/03 | 日証協 | 70,124株 | -6.11% | 46,014株 | +24.67% | 79,195株 | -14.47% | 12,200株 | -23.28% |
| 2014/09/26 | 日証協 | 74,688株 | -14.11% | 36,909株 | +117.51% | 92,595株 | -5.99% | 15,901株 | +341.57% |
| 2014/09/19 | 日証協 | 86,957株 | -3.55% | 16,969株 | -23.11% | 98,495株 | -6.64% | 3,601株 | -32.48% |
| 2014/09/12 | 日証協 | 90,157株 | -3.68% | 22,069株 | -9.55% | 105,495株 | -0.03% | 5,333株 | -20.59% |
| 2014/09/05 | 日証協 | 93,603株 | +4.58% | 24,400株 | +23.86% | 105,526株 | +2.57% | 6,716株 | -59.3% |
| 2014/08/29 | 日証協 | 89,503株 | -13.27% | 19,700株 | +285.14% | 102,880株 | +7.49% | 16,502株 | +125.04% |
| 2014/08/22 | 日証協 | 103,203株 | -0.48% | 5,115株 | -75.99% | 95,711株 | -0.8% | 7,333株 | -74.97% |
| 2014/08/15 | 日証協 | 103,703株 | +20.01% | 21,300株 | -55.74% | 96,479株 | +22.14% | 29,300株 | +107.64% |
| 2014/08/08 | 日証協 | 86,413株 | -4.31% | 48,125株 | +325.32% | 78,992株 | +3.55% | 14,111株 | +171.37% |
| 2014/08/01 | 日証協 | 90,303株 | +1.86% | 11,315株 | +96.3% | 76,284株 | -6.95% | 5,200株 | +173.68% |
| 2014/07/25 | 日証協 | 88,657株 | -6.24% | 5,764株 | -75.37% | 81,985株 | -4.44% | 1,900株 | -5.52% |
| 2014/07/18 | 日証協 | 94,557株 | -7.62% | 23,400株 | -31.22% | 85,795株 | -4.34% | 2,011株 | -79.17% |
| 2014/07/11 | 日証協 | 102,357株 | +10.38% | 34,023株 | +12.39% | 89,685株 | -8.98% | 9,654株 | -6.28% |
| 2014/07/04 | 日証協 | 92,731株 | +1.13% | 30,272株 | +18.91% | 98,528株 | +5.42% | 10,301株 | +572.83% |
| 2014/06/27 | 日証協 | 91,691株 | -1.29% | 25,458株 | -51.34% | 93,458株 | -1.96% | 1,531株 | -77.49% |
| 2014/06/20 | 日証協 | 92,891株 | +3.46% | 52,313株 | -15.88% | 95,328株 | -0.21% | 6,802株 | -16.02% |
| 2014/06/13 | 日証協 | 89,781株 | +11.3% | 62,190株 | +196.74% | 95,527株 | -5.16% | 8,100株 | +68.71% |
| 2014/06/06 | 日証協 | 80,665株 | +1.13% | 20,958株 | +183.22% | 100,727株 | -1.47% | 4,801株 | +9.09% |
※株式分割は考慮していませんのでご注意ください。
Page Top